baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ATI INC. DL-,01/ US01741R1023 /

2024-04-25 7:00:40 PM	Chg. +0.540	Volume	Bid7:00:40 PM	Ask7:00:40 PM	Market Capitalization	Dividend Y.	P/E Ratio
45.980EUR	+1.19%	- Turnover: -	45.980Bid Size: -	46.220Ask Size: -	5.89 bill.EUR	-	-

GlobeNewswire 03-27 William & Mary Campus Mass Notification Drill Using ATI Systems’ Mass Notiﬁcation Solution

GlobeNewswire 03-12 Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks

GlobeNewswire 02-13 Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

GlobeNewswire 02-06 Seoul Robotics to Pursue Initial Public Offering with Samsung Securities as it Expands OEM Partnersh...

GlobeNewswire 01-25 Confluent Announces Significant Investment in ATI Nitinol Melt Expansion

GlobeNewswire 01-17 IBN Coverage Initiated for Astrotech Corp.

GlobeNewswire 01-16 Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review

GlobeNewswire 2023-12-27 Eco Bright Future, Inc. Announces Signing of "Letter-of-Intent" With United Heritage, Sociedad Anoni...

GlobeNewswire 2023-12-12 Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary

GlobeNewswire 2023-12-05 American Trust Insurance Joins World Insurance Associates

GlobeNewswire 2023-11-27 ATI Systems Honored with 2023 ‘ASTORS’ Homeland Security Award

GlobeNewswire 2023-11-13 Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (AT...

GlobeNewswire 2023-11-06 Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

GlobeNewswire 2023-10-27 Strategic Advisory Board Elevates sureti’s Property Claims Resolution Capabilities

GlobeNewswire 2023-10-25 Excision BioTherapeutics Presents Positive Interim Clinical Data from Ongoing Phase 1/2 Trial of EBT...

GlobeNewswire 2023-10-23 ATI PHYSICAL THERAPY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti...

GlobeNewswire 2023-10-19 Excision BioTherapeutics Announces Presentation of Interim Clinical Data for EBT-101 in Latent HIV a...

GlobeNewswire 2023-10-03 Aclaris Therapeutics Completes Enrollment in Phase 2b Study of ATI-1777 for Mild to Severe Atopic De...

GlobeNewswire 2023-09-30 ATI PHYSICAL THERAPY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti...

GlobeNewswire 2023-09-19 ATI PHYSICAL THERAPY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti...

GlobeNewswire 2023-09-18 Aclaris Therapeutics Announces Positive Results from Phase 1 Multiple Ascending Dose Trial of ATI-21...

GlobeNewswire 2023-08-30 Churchill Franklin Automotive Launches Airbag Alert News Service

GlobeNewswire 2023-08-17 Excision BioTherapeutics Announces Gene Therapy Publication of Pre-Clinical Data Supporting its Firs...

Newsfile Corp 2023-01-17 BeWhere and Assured Telematics Launch First of Its Kind Forklift Tracking and Management with Hiab I...

Newsfile Corp 2022-06-29 WIR Group to Build Metaverse Platform for Mediterranean Countries

ATI INC. DL-,01/ US01741R1023 /

If you wish to receive reply to your feedback, please provide your email address.